Company Profiles

driven by the PitchBook Platform

AbGenomics International

AbGenomics International
2000 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$16M LATEST DEAL AMOUNT
$48.6M TOTAL AMOUNT RAISED
Description

Developer of antibody therapeutics designed for the treatment of cancer and immune-related inflammatory diseases. The company's antibody therapeutics focus on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates (ADC) therapy as well as creates a linker-payload that can be utilized for different targeted tumor indications, providing patients with long term drug-free remission of other immune-mediated diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Primary Office
San Francisco, CA
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbGenomics International’s full profile, request a free trial.

AbGenomics International Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 06-Oct-2014 $16M $48.6M Completed Generating Revenue
3. Angel (individual) 18-Jul-2013 00.00 000.00 Completed Generating Revenue
2. Angel (individual) 15-Jun-2012 $16.9M $23M Completed Generating Revenue
1. Angel (individual) 16-Jul-2008 $6.15M $6.15M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

AbGenomics International Executive Team (8)

Name Title Board
Seat
Contact
Info
Rong-Hwa Lin Ph.D Chief Executive Officer, Founder & Chairman
Jim Early Chief Financial Officer
Leewen Lin Ph.D Chief Operating Officer
Cheng-Chi Chao Ph.D Senior Director, Technology and Business Development
Chen-Yu Fan Vice President, Finance
You’re viewing 5 of 8 executives. Get the full list »

AbGenomics International Board Members (9)

Name Representing Role Since Contact
Info
Chia Yang Self Board Member 000 0000
Chung Yung-Hua Self Board Member 000 0000
Kim Graham AbGenomics International Board Member 000 0000
Nai-Yu Pai AbGenomics International Board Member 000 0000
Stephen Polmar MD AbGenomics International Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »